Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis …
TE Banks, M Rajapaksha, LH Zhang, F Bai… - European Journal of …, 2022 - Elsevier
This study aims to investigate whether stabilization of glucagon-like peptide-1 (GLP-1) level
reduces angiotensin II (Ang II)-induced cardiac fibrosis and-elevated blood pressure …
reduces angiotensin II (Ang II)-induced cardiac fibrosis and-elevated blood pressure …
Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis …
TE Banks, M Rajapaksha, LH Zhang… - European journal …, 2022 - pubmed.ncbi.nlm.nih.gov
This study aims to investigate whether stabilization of glucagon-like peptide-1 (GLP-1) level
reduces angiotensin II (Ang II)-induced cardiac fibrosis and-elevated blood pressure …
reduces angiotensin II (Ang II)-induced cardiac fibrosis and-elevated blood pressure …
Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis …
TE Banks, M Rajapaksha, LH Zhang, F Bai… - European Journal of …, 2022 - europepmc.org
This study aims to investigate whether stabilization of glucagon-like peptide-1 (GLP-1) level
reduces angiotensin II (Ang II)-induced cardiac fibrosis and-elevated blood pressure …
reduces angiotensin II (Ang II)-induced cardiac fibrosis and-elevated blood pressure …